Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports 9 Months Consolidated Results
Company Name : Egyptian International Pharmaceuticals (EIPICO)
ISIN Code : EGS38081C013
Currency : EGP
F/S Consolidated Period : From 01/01/2023 To 30/09/2023
Net Profit : 644,146,120
F/S Consolidated Period : From 01/01/2022 To 30/09/2022
Net Comparative Profit : 417,790,339
Audit Status : Reviewed
Source : Egyptian International Pharmaceuticals (EIPICO)
The BoD Report in Arabic (251 KB)
The BoD Report in English (378 KB)
ISIN Code : EGS38081C013
Currency : EGP
F/S Consolidated Period : From 01/01/2023 To 30/09/2023
Net Profit : 644,146,120
F/S Consolidated Period : From 01/01/2022 To 30/09/2022
Net Comparative Profit : 417,790,339
Audit Status : Reviewed
Source : Egyptian International Pharmaceuticals (EIPICO)
The BoD Report in Arabic (251 KB)
The BoD Report in English (378 KB)
Comments